BR · Analyze — Financebot

Date: 2026-08-04 | Price: $168.41 | Market cap: $19.48B | FY ends June 30 Prior file: analyze-2026-03-21.md at $174.36 · −3.4% in four and a half months

Headline: FY26 delivered, and the reason the market sold it in March reversed

The March file has aged into a useful control. In four and a half months the stock is −3.4%. In that same window Broadridge finished a fiscal year with +9% revenue and +12% adjusted EPS, raised the dividend for the 20th consecutive year, and authorized a $1.5B buyback. Business up double digits, price down. That gap is the whole opportunity.

Q4 FY2026 (quarter ended 2026-06-30):

	Q4 FY26	Q4 FY25	Δ
Revenue	$2.22B	$2.07B	+7%
Recurring revenue (cc)	$1.5B		+8%
Diluted EPS (GAAP)	$3.44	$3.16	+9%
Adjusted EPS	$3.82		+8%

Full year FY2026: revenue $7.48B (+9%) · recurring revenue $4.9B (+8%) · adjusted EPS $9.60 (+12%) · record closed sales of $305M.

The Q3 bear case did not survive Q4

The stock's de-rating had a specific, quotable cause. From the Q3 FY26 reaction: "adjusted operating income margin fell 90bps, and closed sales decreased both quarterly and year-to-date." Investors sold a margin-and-sales-momentum story, not a valuation story.

FY26 closed the year at a record $305M of closed sales. The precise metric that broke in Q3 finished the year at an all-time high, and FY27 is guided to +6–8% recurring revenue growth (cc) and +8–12% adjusted EPS growth — the same algorithm the company has hit for a decade.

Financial health

(FY2025 = year ended 2025-06-30, the last full year in the statement tables; FY2026 figures from the 2026-08-04 release.)

Fiscal year	2022	2023	2024	2025	2026
Revenue	$5.71B	$6.06B	$6.51B	$6.89B	$7.48B
Growth		+6.1%	+7.4%	+5.8%	+8.6%
Operating income	$760M	$936M	$1.02B	$1.19B	—
Operating margin	13.3%	15.4%	15.7%	17.3%	—
Net income	$539M	$631M	$698M	$840M	—
Diluted EPS	$4.55	$5.30	$5.86	$7.10	$9.60 (adj)
FCF	$370M	$748M	$943M	$1.06B	—
Diluted shares	118.5M	119.0M	119.1M	118.3M	—

Revenue growth is accelerating, not decaying — 6.1% → 7.4% → 5.8% → 8.6%. Operating margin expanded 400bps in three years (13.3% → 17.3%). FCF compounded at 41.8% over three years and OCF at 38.2%, against a 6.5% revenue CAGR — this is operating leverage in the classic form, and it is the single strongest cash-conversion record on the watchlist.

Capex is $115M on $6.89B of revenue (1.7%). There is no capex cliff here either.

Capital allocation — the one genuine criticism, now being addressed:

	FY22	FY23	FY24	FY25
Dividends	$291M	$331M	$368M	$402M
Buybacks	$23M	$24M	$485M	$135M
Acquisitions	$13M	$0	$34M	$194M
Total debt	$4.07B	$3.65B	$3.58B	$3.46B

Share count has been flat (−0.1% CAGR over three years) — buybacks have mostly offset SBC rather than retiring stock, and FY25's $135M was a step down from FY24's $485M. The new $1.5B authorization is 7.7% of the market cap and, at a 15.9× forward multiple, is the right use of cash. Whether it actually gets spent is the thing to watch, not the announcement.

Debt fell $4.07B → $3.46B across four years while dividends grew 38%. Debt/assets 40.5%.

✅ Diagnostic check: net margin 15% < operating margin 18%. No equity-mark distortion ([[pitfall-unrealized-equity-marks-break-headline-pe]] does not fire). Reported earnings are operating earnings.

⚠️ DYT caution. Yield is 2.59% against a 5-year average of 1.64% — which looks like a strong Dividend Yield Theory buy signal. But per [[pitfall-dyt-inverts-when-price-caused-the-yield]], the yield can rise two ways and both are live here: the dividend rose 12% and the price fell 38%. The signal is real but roughly two-thirds of it is the price. Do not present the DYT reading as independent confirmation of the FCF-based case — it is the same fact counted twice.

Moat

Broadridge processes 80–90%+ of all proxy communications in North America and generates over 7 billion communications a year. This is regulated-monopoly-adjacent infrastructure: brokers are required to deliver proxy materials to beneficial owners, and Broadridge is how essentially all of them do it. Revenue retention is 98%. Switching means re-plumbing a compliance obligation.

Segments: Investor Communication Solutions ~65% of revenue (the moat), Global Technology & Operations ~35% (SaaS trade/post-trade/wealth platforms).

The stress test — and the two bear cases, honestly weighted

1. NYSE proxy fee review — the real one. Broadridge's proxy distribution fees are set by the NYSE proxy working group under SEC oversight. Broadridge does not price its most profitable revenue line; a regulator does. A fee review is the one event that could reset ICS economics without any competitor doing anything, and there is nothing Broadridge can do to prevent it. It is a genuine, structural, unhedgeable risk.

What limits it: it is undated and perennial — this committee has existed for years, fee reform has been "recommended" before, and the process runs on a multi-year clock with public comment. It is a risk to underwrite, not a catalyst to trade. Asset-manager fee pressure in the mutual fund / ETF interim business is the same risk in commercial form.

2. Tokenization and AI "disrupting the plumbing" — the overstated one. The narrative says tokenized securities and digital delivery route around Broadridge. The evidence says the opposite: Broadridge's own DLR platform ran $360B/day in tokenized repo volume in June, roughly 3× year over year, and in May 2026 it extended proxy voting and disclosure to support all models of third-party-custodied tokenized securities. Tokenized assets still need proxy voting, disclosure and settlement — and Broadridge is building the rails for them.

That is the asymmetry the market is mispricing. It sold BR as the disrupted incumbent while BR was booking 3× growth in the disrupting technology. Digitization of communications does compress per-piece distribution economics over time — that part is fair — but it compresses a cost line as fast as a revenue line, and the FY26 margin expansion is evidence it is being managed.

Evergreen rating: 8.5/10. Regulatory dependency is the ceiling; nothing else on the watchlist has a more entrenched position in a legally mandated workflow.

Valuation

FY27 guidance: recurring revenue +6–8% cc, adjusted EPS +8–12% → $10.37–10.75, midpoint $10.56.

Method	Input	Result
Forward P/E	$168.41 ÷ $10.56	15.9×
Trailing P/E	on $9.35 ttm GAAP	18.0×
EV/EBITDA		12.1×
P/FCF	$168.41 ÷ $8.93 (FY25)	18.9×
Graham IV	√(22.5 × 7.10 × 24.36)	$71.59 — floor only
Dividend Yield Theory	2.59% vs 1.64% 5yr avg	⚠️ see caution above
Bogle expected return	2.59% yield + ~10% adj EPS growth	~12.6% + multiple change
Consensus target		$206.50 (+22.6%)

Bogle is the load-bearing model here and it does not need heroic assumptions: the current yield plus the midpoint of management's own guide returns ~12.6% annually with no multiple re-rating at all. Any move back toward the historical multiple is upside on top.

Fair value: $190–230, central $211. That is 18–22× FY27 adjusted EPS. Deliberately below the 25–30× BR commanded historically — the disruption narrative and the fee-review risk justify a permanently lower multiple, and I am not modelling a return to the old band.

At $168.41 the stock is ~25% below central fair value and 38.1% below its 52-week high of $271.91 set in August 2025.

Verdict — 🟢 ACCUMULATE · conviction [8.5], held — and the zone re-opens

The correction to the watchlist: BR was marked "❌ ZONE EXITED" against a fair value that predates FY26 results. With the year delivered ($7.48B / $9.60 adj EPS) and FY27 guided, fair value moves to $190–230, and $168.41 is back inside the buy zone — not marginally, but ~25% below the centre.

Three things carry the [8.5], which remains the highest conviction on the watchlist:

The record is unambiguous. Revenue accelerating to +8.6%, operating margin +400bps in three years, FCF compounding 41.8%, debt down $600M, and a 20th consecutive dividend increase (+12% to $4.36). Twenty-year dividend streaks are not awarded to businesses with deteriorating economics.
The specific reason for the de-rating reversed. Q3's collapsing closed sales became FY26's record $305M. The bear thesis was falsifiable and it was falsified.
The disruption fear is inverted. DLR tokenized repo at $360B/day, ~3× YoY, plus proxy support extended to all tokenized-custody models. BR is the vendor to the transition.

Why not [9.0]: the NYSE proxy fee review is a real structural risk on ~65% of revenue that Broadridge cannot control, share count has been flat for three years, and FY27's guide is the same 8–12% algorithm the market has already decided to distrust. A 15.9× multiple on a business this defensive is the market pricing regulatory risk, not stupidity — it is just pricing more of it than the evidence supports.

Zones: entry $150–180 (in zone at $168.41). Trim 22× fwd. Yield 2.59% at a 41% payout with two decades of increases behind it — this is the income sleeve's anchor.

A portfolio-specific passage was removed from the public build.

The three prints together

All three of today's names are in "Information Technology Services" by Yahoo's classification. They are not remotely the same business, and the market ranked them backwards today:

	Move	Revenue	Operating income (3–4yr)	FCF	Fwd P/E	vs FV
IT	+19.0%	guided −1.9%	+6.3%	guided flat	13.3×	+8% above centre
LDOS	+8.8%	+7%	+86%	+23.5% CAGR	10.6×	−19% below centre
BR	+5.6%¹	+8.6%	+57%	+41.8% CAGR	15.9×	−20% below centre

¹ since 7/29, not a single-session move.

The biggest one-day gain went to the only one of the three whose operating income has not grown and whose revenue is guided down. Gartner's EPS growth is share-count arithmetic funded partly with new debt; Leidos and Broadridge both grew operating income faster than revenue and funded their buybacks from cash flow. Today's tape paid for the adjustment, not the business.